Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Ultragenyx Pharmaceutical Inc. Notice of April 6, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
-
Ultragenyx Pharmaceutical Inc. Notice of April 6, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
-
Navan, Inc. Notice of April 24, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
-
Navan, Inc. Notice of April 24, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
-
CoreWeave, Inc. Notice of March 13, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
-
CoreWeave, Inc. Notice of March 13, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
-
Corcept Therapeutics Incorporated Securities Fraud Class Action Result of FDA Approval Issues and 50% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
-
Corcept Therapeutics Incorporated Securities Fraud Class Action Result of FDA Approval Issues and 50% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
-
Ardent Health Corporation Securities Fraud Class Action Result of Undisclosed Collections Problems and 33% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
-
BellRing Brands, Inc. Securities Fraud Class Action Result of Inventory Issues and 52% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
-
Ardent Health Corporation Securities Fraud Class Action Result of Undisclosed Collections Problems and 33% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
-
BellRing Brands, Inc. Securities Fraud Class Action Result of Inventory Issues and 52% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
-
HII’s Ingalls Shipbuilding Authenticates Keel of Philadelphia (LPD 32)
-
Pender Growth Fund Provides Financial Highlights and Company Updates
-
Aura Announces Credit Rating Upgrade on Global Scale to ‘BB-’ From ‘B+’ and on Brazilian National Scale to ‘brAA+’ From ‘brAA’, Both With Outlook Revised to Stable
-
GalaxyEdge Acquisition Corp Prices $100 Million Initial Public Offering
-
How to Celebrate National Hair Removal Day in 2026
-
Gran Tierra Energy Inc. Announces 2025 Fourth Quarter & Year-End Results
-
Gran Tierra Energy Inc. Announces 2025 Fourth Quarter & Year-End Results
-
Historic Day for the City: Chicago Fire FC Breaks Ground on Privately Funded Soccer Stadium at The 78
-
Kayne Anderson Energy Infrastructure Fund Provides Unaudited Balance Sheet Information and Announces Its Net Asset Value and Asset Coverage Ratios As of February 28, 2026
-
Alaris Equity Partners Announces Timing of 2025 Q4 Financial Results, Conference Call and Webcast
-
VeeaVision AI for Real-Time Intelligent Visual Automation with IoT Data Fusion — Powered by TerraFabric™
-
NFI Group Hosts Ribbon-Cutting Ceremony to Officially Open New Flyer’s All-Canadian Build Facility in Winnipeg
-
ATI Advisory Welcomes Former Wisconsin Medicaid Director Bill Hanna as Practice Director of Payer Strategy and Program Design
-
Brookfield Asset Management Announces $1 Billion Commercial Paper Program
-
CFS-Ontario holds a rally at Queen’s Park against OSAP changes
-
Petrus Resources Declares Monthly Dividend for March 2026
-
Sprott Focus Trust, Inc. (Nasdaq-FUND) Declares First Quarter Common Stock Distribution of $0.1335 Per Share
-
Apollo Announces 2026 Annual Meeting of Stockholders
-
Quipt Home Medical Announces Voting Results From Special Meeting of Shareholders
-
Teva and Blackstone Life Sciences Announce $400 Million Strategic Growth Capital Agreement to Advance duvakitug
-
InterCure Receives Nasdaq Notification Regarding Minimum Bid Requirement
-
Terra Clean Provides Corporate Update
-
Tonix Pharmaceuticals to Present Poster on Tonmya™ at the 2026 American Academy of Pain Medicine PainConnect Annual Meeting
-
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Capital Power declares dividends for its Common and Preference shares
-
Eton Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, March 19, 2026
-
Castle Biosciences Announces Grand Opening of New Corporate Headquarters in Friendswood, Texas
-
Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of February 28, 2026
-
ProQR Announces Webcast of Presentation at the 2026 Citizens Life Sciences Conference
-
Kraken Robotics Announces Signing of Strategic Acquisition to Expand Global Maritime Capabilities
-
Rivermate Empowers Businesses to Scale Globally with Employer of Record Services
-
Dave Announces Proposed Offering of Convertible Notes
-
Fuel Tech Reports 2025 Fourth Quarter and Full Year Financial Results
-
Uniti Group Inc. to Participate at the Deutsche Bank 34th Annual Media, Internet & Telecom Conference
-
Roivant Announces Genevant Sciences’ and Arbutus Biopharma’s $2.25 Billion Global Settlement With Moderna
-
Genevant Sciences and Arbutus Biopharma Announce $2.25 Billion Global Settlement With Moderna
-
Anaptys Provides Update on Business Separation and Announces Fourth Quarter and Full Year 2025 Financial Results
-
Uniti Group Inc. to Participate at the Deutsche Bank 34th Annual Media, Internet & Telecom Conference
